Christian Angermayer, 10% Owner at ATAI Life Sciences N.V. (ATAI), bought 132,020 shares at $4.69 ($617K) on 2022-04-26, disclosed to the SEC on 2022-04-28.
Open-market purchase of $617k ATAI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.69 | 46,207 | $217K | 35.1% |
| 2 | $4.69 | 46,207 | $217K | 35.1% |
| 3 | $4.64 | 19,803 | $92K | 14.9% |
| 4 | $4.64 | 19,803 | $92K | 14.9% |
| Total | $4.68 avg | 132,020 | $617K | 100% |
| Filing → |
| ATAI | BUY | 2022-05-02 | $253K | — | Filing → |
| ATAI | BUY | 2022-04-26 | $553K | — | Filing → |
| ATAI | BUY | 2022-04-14 | $539K | — | Filing → |